CA1306260C
(en)
*
|
1985-10-18 |
1992-08-11 |
Shionogi & Co., Ltd. |
Condensed imidazopyridine derivatives
|
US4942168A
(en)
*
|
1987-07-13 |
1990-07-17 |
Hoechst-Roussel Pharmaceuticals Inc. |
Hydroxyquinoline amines, and method of enhancing memory in mammals
|
CA1335996C
(en)
*
|
1988-02-16 |
1995-06-20 |
Susumu Takada |
2-substituted carbonylimidazo¬4,5-c|quinolines
|
EP0361489A3
(de)
*
|
1988-09-30 |
1991-06-12 |
Chugai Seiyaku Kabushiki Kaisha |
3,4-Diaminochinolin- und Pyridinverbindungen
|
EP0385630B1
(de)
*
|
1989-02-27 |
1996-11-27 |
Riker Laboratories, Inc. |
4-Amino-1H-Imidazo(4,5-c)chinoline als antivirale Mittel
|
CA2011504C
(en)
*
|
1989-03-07 |
1998-06-02 |
Kenji Ohmori |
Imidazoquinolone derivatives
|
US4929624A
(en)
*
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
CA2021338C
(en)
*
|
1989-07-18 |
1996-07-16 |
Fumio Suzuki |
Imidazoquinolone derivatives
|
US4988815A
(en)
*
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
FR2654021B1
(fr)
*
|
1989-11-07 |
1992-02-28 |
Simond Jacques |
Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
|
GB8928281D0
(en)
*
|
1989-12-14 |
1990-02-21 |
Smith Kline French Lab |
Compounds
|
ES2094772T3
(es)
*
|
1990-06-01 |
1997-02-01 |
Kyowa Hakko Kogyo Kk |
Derivados de imidazonaftiridinas.
|
DE69229114T2
(de)
*
|
1991-03-01 |
1999-11-04 |
Minnesota Mining And Mfg. Co., Saint Paul |
1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine
|
US5266575A
(en)
*
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
US5395937A
(en)
*
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
US5693811A
(en)
*
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
US6069149A
(en)
*
|
1997-01-09 |
2000-05-30 |
Terumo Kabushiki Kaisha |
Amide derivatives and intermediates for the synthesis thereof
|
JPH10298181A
(ja)
*
|
1997-04-25 |
1998-11-10 |
Sumitomo Pharmaceut Co Ltd |
タイプ2ヘルパーt細胞選択的免疫応答抑制剤
|
JP2000119271A
(ja)
|
1998-08-12 |
2000-04-25 |
Hokuriku Seiyaku Co Ltd |
1h―イミダゾピリジン誘導体
|
WO2003035626A2
(en)
*
|
2001-10-23 |
2003-05-01 |
Applied Research Systems Ars Holding N.V. |
Azole derivatives and pharmaceutical compositions containing them
|
GB0211649D0
(en)
*
|
2002-05-21 |
2002-07-03 |
Novartis Ag |
Organic compounds
|
WO2004009593A1
(en)
|
2002-07-23 |
2004-01-29 |
Biogal Gyogyszergyar Rt. |
Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates
|
SI1539752T1
(sl)
|
2002-07-26 |
2007-08-31 |
Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag |
Priprava 1H-imidazo(4,5-c)kinolin-4-aminov preko novih imidazo(4,5-c)kinolin-4-ciano in 1H-imidazo(4,5-c)kinolin-4- karboksamidnih intermediatov
|
WO2005018556A2
(en)
|
2003-08-12 |
2005-03-03 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo-containing compounds
|
ES2406730T3
(es)
|
2003-08-27 |
2013-06-07 |
3M Innovative Properties Company |
Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
|
AU2004270201A1
(en)
|
2003-09-05 |
2005-03-17 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
CA2536530A1
(en)
|
2003-10-01 |
2005-04-14 |
Taro Pharmaceuticals U.S.A., Inc. |
Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof
|
CA2540541C
(en)
|
2003-10-03 |
2012-03-27 |
3M Innovative Properties Company |
Alkoxy substituted imidazoquinolines
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
ITMI20032121A1
(it)
*
|
2003-11-04 |
2005-05-05 |
Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm |
Procedimento per la preparazione di imiquimod e suoi intermedi
|
EP1685129A4
(de)
|
2003-11-14 |
2008-10-22 |
3M Innovative Properties Co |
Oximsubstituierte imidazoringverbindungen
|
WO2005048945A2
(en)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo ring compounds
|
JP4891088B2
(ja)
|
2003-11-25 |
2012-03-07 |
スリーエム イノベイティブ プロパティズ カンパニー |
置換されたイミダゾ環系および方法
|
JP2007517035A
(ja)
|
2003-12-29 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
|
CA2551399A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
CA2559863A1
(en)
|
2004-03-24 |
2005-10-13 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
US8017779B2
(en)
|
2004-06-15 |
2011-09-13 |
3M Innovative Properties Company |
Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
US7915281B2
(en)
|
2004-06-18 |
2011-03-29 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
WO2006038923A2
(en)
|
2004-06-18 |
2006-04-13 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
AU2005322898B2
(en)
|
2004-12-30 |
2011-11-24 |
3M Innovative Properties Company |
Chiral fused (1,2)imidazo(4,5-c) ring compounds
|
AU2005326708C1
(en)
|
2004-12-30 |
2012-08-30 |
3M Innovative Properties Company |
Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
|
CA2597092A1
(en)
|
2005-02-04 |
2006-08-10 |
Coley Pharmaceutical Group, Inc. |
Aqueous gel formulations containing immune reponse modifiers
|
WO2006086634A2
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
EP1869043A2
(de)
|
2005-04-01 |
2007-12-26 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridin-1,4-diamine und analoge davon
|
CA2602590A1
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
JP2009504803A
(ja)
|
2005-08-22 |
2009-02-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Tlrアゴニスト
|
US8846697B2
(en)
|
2006-05-31 |
2014-09-30 |
The Regents Of The University Of California |
Purine analogs
|
WO2008008432A2
(en)
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
|
EA019151B1
(ru)
|
2007-02-07 |
2014-01-30 |
Дзе Регентс Оф Дзе Юниверсити Оф Калифорния |
Конъюгаты синтетических агонистов tlr и их применение
|
EP2009002A1
(de)
*
|
2007-06-21 |
2008-12-31 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Neues Verfahren zur Herstellung von 1H-imidazo [4,5-c]-chinolin-Ringsystemen
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
SG173617A1
(en)
|
2009-02-11 |
2011-09-29 |
Univ California |
Toll-like receptor modulators and treatment of diseases
|
HUE033901T2
(en)
*
|
2010-08-17 |
2018-01-29 |
3M Innovative Properties Co |
Formulations and formulations for lipidized immune response modifying compounds and related processes
|
US8728486B2
(en)
|
2011-05-18 |
2014-05-20 |
University Of Kansas |
Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
|
EP2763677B1
(de)
*
|
2011-10-04 |
2020-02-26 |
Janus Biotherapeutics, Inc. |
Neue immunsystemmodulatoren auf imidazolchinolin-basis
|
CN104968200B
(zh)
*
|
2013-02-01 |
2018-03-06 |
维尔斯达医疗公司 |
具有抗炎、抗真菌、抗寄生物和抗癌活性的胺化合物
|
BR112015022923A2
(pt)
|
2013-03-15 |
2017-07-18 |
Syngenta Participations Ag |
derivados de imidazopiridina microbicidamente ativos
|
ES2538880B1
(es)
*
|
2013-12-24 |
2016-09-08 |
Laboratorios Viñas S.A. |
Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
|
CN105899539B
(zh)
|
2014-01-10 |
2021-11-09 |
博笛生物科技有限公司 |
用于免疫疗法的化合物和组合物
|
EP4001311A1
(de)
|
2014-07-09 |
2022-05-25 |
Birdie Biopharmaceuticals Inc. |
Anti-pd-l1-kombinationen zur tumorbehandlung
|
CN108137586B
(zh)
*
|
2015-09-14 |
2021-04-13 |
辉瑞大药厂 |
作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
|
CN106943596A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技(北京)有限公司 |
用于治疗肿瘤的抗-cd20组合
|
CN106943597A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技(北京)有限公司 |
用于治疗肿瘤的抗-egfr组合
|
US10533007B2
(en)
|
2016-04-19 |
2020-01-14 |
Innate Tumor Immunity, Inc. |
NLRP3 modulators
|
MX2018012249A
(es)
|
2016-04-19 |
2019-02-07 |
Innate Tumor Immunity Inc |
Moduladores de nlpr3.
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
TWI674261B
(zh)
|
2017-02-17 |
2019-10-11 |
美商英能腫瘤免疫股份有限公司 |
Nlrp3 調節劑
|
CN118515666A
(zh)
|
2017-04-27 |
2024-08-20 |
博笛生物科技有限公司 |
2-氨基-喹啉衍生物
|
JP7080501B2
(ja)
|
2017-06-23 |
2022-06-06 |
バーディー バイオファーマシューティカルズ インコーポレイテッド |
医薬品組成物
|
FR3113287B1
(fr)
|
2020-08-07 |
2023-06-23 |
Phv Pharma |
Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique
|